Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker CAMP
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | CAMP CAMP4 Therapeutics Corporation | Matthew D. Perry | 6.33M | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | CAMP CAMP4 Therapeutics Corporation | Coastlands Capital LLC | 6.33M | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | CAMP CAMP4 Therapeutics Corporation | Coastlands Capital GP LLC | 6.33M | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | CAMP CAMP4 Therapeutics Corporation | Coastlands Capital Partners LP | 6.33M | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | CAMP CAMP4 Therapeutics Corporation | Coastlands Capital LP | 6.33M | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 12, 2026 | SCHEDULE 13G | CAMP CAMP4 Therapeutics Corporation | Phillip Gross | 4.19M | 6.7% | SCHEDULE 13G ↗ |
| Nov 12, 2026 | SCHEDULE 13G | CAMP CAMP4 Therapeutics Corporation | Robert Atchinson | 4.19M | 6.7% | SCHEDULE 13G ↗ |
| Nov 12, 2026 | SCHEDULE 13G | CAMP CAMP4 Therapeutics Corporation | Adage Capital Management, L.P. | 4.19M | 6.7% | SCHEDULE 13G ↗ |
| Nov 5, 2026 | SCHEDULE 13G/A (amended) | CAMP CAMP4 Therapeutics Corporation | Abigail P. Johnson | 4.91M | 7.8% | SCHEDULE 13G/A ↗ |
| Nov 5, 2026 | SCHEDULE 13G/A (amended) | CAMP CAMP4 Therapeutics Corporation | FMR LLC | 4.91M | 7.8% | SCHEDULE 13G/A ↗ |
| Aug 31, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Kush Parmar | 6.37M | 9.9% | SCHEDULE 13D/A ↗ |
| Aug 31, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Andrew J. Schwab | 6.38M | 9.9% | SCHEDULE 13D/A ↗ |
| Aug 31, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | 5AM Opportunities II (GP), LLC | 302,770 | 0.5% | SCHEDULE 13D/A ↗ |
| Aug 31, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | 5AM Opportunities II, L.P. | 302,770 | 0.5% | SCHEDULE 13D/A ↗ |
| Aug 31, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | 5AM Partners VII, LLC | 4.03M | 6.3% | SCHEDULE 13D/A ↗ |
| Aug 31, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | 5AM Ventures VII, L.P. | 4.03M | 6.3% | SCHEDULE 13D/A ↗ |
| Aug 31, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | 5AM Partners VI, LLC | 2.03M | 3.2% | SCHEDULE 13D/A ↗ |
| Aug 31, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | 5AM Ventures VI, L.P. | 2.03M | 3.2% | SCHEDULE 13D/A ↗ |
| Aug 19, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Amy Schulman | 909,090 | 1.4% | SCHEDULE 13D/A ↗ |
| Aug 19, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Brian Chee | 909,090 | 1.4% | SCHEDULE 13D/A ↗ |
| Aug 19, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Amir Nashat | 3.93M | 6.3% | SCHEDULE 13D/A ↗ |
| Aug 19, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Polaris Partners X, L.P. | 909,090 | 1.4% | SCHEDULE 13D/A ↗ |
| Aug 19, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Polaris Partners GP X, L.L.C. | 909,090 | 1.4% | SCHEDULE 13D/A ↗ |
| Aug 19, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Polaris Entrepreneurs' Fund VII, L.P. | 197,661 | 0.3% | SCHEDULE 13D/A ↗ |
| Aug 19, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Polaris Partners VII, L.P. | 2.83M | 4.5% | SCHEDULE 13D/A ↗ |
| Aug 19, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Polaris Management Co. VII, L.L.C. | 3.02M | 4.8% | SCHEDULE 13D/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | CAMP CAMP4 Therapeutics Corporation | Dmitry Balyasny | 2.59M | 5.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | CAMP CAMP4 Therapeutics Corporation | Dames GP LLC | 2.59M | 5.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | CAMP CAMP4 Therapeutics Corporation | Balyasny Asset Management Holdings LP | 2.59M | 5.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | CAMP CAMP4 Therapeutics Corporation | Bam GP LLC | 2.59M | 5.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | CAMP CAMP4 Therapeutics Corporation | Balyasny Asset Management L.P. | 2.59M | 5.0% | SCHEDULE 13G/A ↗ |
| Aug 10, 2026 | SCHEDULE 13G | CAMP CAMP4 Therapeutics Corporation | Ortav Yehudai | 3.79M | 6.0% | SCHEDULE 13G ↗ |
| Aug 10, 2026 | SCHEDULE 13G | CAMP CAMP4 Therapeutics Corporation | Trails Edge Biotechnology Master Fund, LP | 3.79M | 6.0% | SCHEDULE 13G ↗ |
| Aug 10, 2026 | SCHEDULE 13G | CAMP CAMP4 Therapeutics Corporation | Trails Edge Capital Partners, LP | 3.79M | 6.0% | SCHEDULE 13G ↗ |
| Aug 5, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Kush Parmar | 6.30M | 9.9% | SCHEDULE 13D/A ↗ |
| Aug 5, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Andrew J. Schwab | 6.31M | 9.9% | SCHEDULE 13D/A ↗ |
| Aug 5, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | 5AM Opportunities II (GP), LLC | 302,770 | 0.5% | SCHEDULE 13D/A ↗ |
| Aug 5, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | 5AM Opportunities II, L.P. | 302,770 | 0.5% | SCHEDULE 13D/A ↗ |
| Aug 5, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | 5AM Partners VII, LLC | 3.38M | 5.3% | SCHEDULE 13D/A ↗ |
| Aug 5, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | 5AM Ventures VII, L.P. | 3.38M | 5.3% | SCHEDULE 13D/A ↗ |
| Aug 5, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | 5AM Partners VI, LLC | 2.63M | 4.2% | SCHEDULE 13D/A ↗ |
| Aug 5, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | 5AM Ventures VI, L.P. | 2.63M | 4.2% | SCHEDULE 13D/A ↗ |
| May 15, 2026 | SCHEDULE 13G | CAMP CAMP4 Therapeutics Corporation | Dmitry Balyasny | 2.63M | 5.1% | SCHEDULE 13G ↗ |
| May 15, 2026 | SCHEDULE 13G | CAMP CAMP4 Therapeutics Corporation | Dames GP LLC | 2.63M | 5.1% | SCHEDULE 13G ↗ |
| May 15, 2026 | SCHEDULE 13G | CAMP CAMP4 Therapeutics Corporation | Balyasny Asset Management Holdings LP | 2.63M | 5.1% | SCHEDULE 13G ↗ |
| May 15, 2026 | SCHEDULE 13G | CAMP CAMP4 Therapeutics Corporation | Bam GP LLC | 2.63M | 5.1% | SCHEDULE 13G ↗ |
| May 15, 2026 | SCHEDULE 13G | CAMP CAMP4 Therapeutics Corporation | Balyasny Asset Management L.P. | 2.63M | 5.1% | SCHEDULE 13G ↗ |
| Mar 11, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Everest Aggregator, LP | 2.50M | 4.8% | SCHEDULE 13D/A ↗ |
| Mar 11, 2026 | SCHEDULE 13D/A (amended) | CAMP CAMP4 Therapeutics Corporation | Enavate Sciences GP, LLC | 2.50M | 4.8% | SCHEDULE 13D/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | CAMP CAMP4 Therapeutics Corporation | Vivo Opportunity Cayman, LLC | 389,577 | 0.8% | SCHEDULE 13G/A ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 11:00 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances